Bismuth H, Castaing D, Ericzon B G, Otte J B, Rolles K, Ringe B, Sloof M
Lancet. 1987 Sep 19;2(8560):674-6. doi: 10.1016/s0140-6736(87)92453-6.
At the 32 European centres where livers are transplanted the actuarial survival rate for 1218 patients was 44% at 1 year and 41% at 2 years. Perioperative mortality (30 days) was 30%. Recipients aged under 15 years had a higher survival rate than those aged over 15; the differences were 22% at 1 year and 32% at 2 years. For the 97 patients who received two or more liver grafts, actuarial survival was 27.7% at 1 and 2 years. Two-thirds of the transplantations were done since 1984. Since then the best results have been obtained for biliary atresia (88 cases; survival rates at 30 days, 1 year, and 2 years were 87%, 74%, and 68%). Primary biliary cirrhosis was the commonest benign indication for transplantation, with survival of 64% at 1 and 2 years. The proportion of transplantations that were done for patients with hepatocellular carcinoma was smaller after than before 1984; among transplantations done in adults after 1984, those done because of hepatocellular carcinoma gave the best perioperative survival rate (76%) but the worst 2 year survival (30.8%).
在32个进行肝脏移植的欧洲中心,1218例患者的精算生存率在1年时为44%,2年时为41%。围手术期死亡率(30天)为30%。15岁以下的受者生存率高于15岁以上者;1年时差异为22%,2年时为32%。接受两次或更多次肝脏移植的97例患者,1年和2年的精算生存率为27.7%。三分之二的移植手术自1984年起进行。自那时以来,胆道闭锁取得了最佳结果(88例;30天、1年和2年的生存率分别为87%、74%和68%)。原发性胆汁性肝硬化是最常见的良性移植指征,1年和2年的生存率为64%。肝细胞癌患者的移植比例在1984年之后比之前有所下降;在1984年之后成人进行的移植手术中,因肝细胞癌进行的移植围手术期生存率最佳(76%),但2年生存率最差(30.8%)。